PRELUDE CAPITAL MANAGEMENT, LLC - SYNERON MEDICAL LTD ownership

SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 61 filers reported holding SYNERON MEDICAL LTD in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of SYNERON MEDICAL LTD
ValueSharesWeighting
Q2 2017$1,258,000
+364.2%
114,926
+346.6%
0.12%
+357.7%
Q1 2017$271,000
-8.1%
25,731
-26.7%
0.03%
-27.8%
Q4 2016$295,000
+656.4%
35,112
+550.2%
0.04%
+800.0%
Q3 2016$39,000
+18.2%
5,400
+25.6%
0.00%
-20.0%
Q2 2016$33,000
+83.3%
4,300
+73.0%
0.01%
+66.7%
Q1 2016$18,000
-60.0%
2,486
-31.2%
0.00%
-50.0%
Q1 2015$45,0003,6160.01%
Other shareholders
SYNERON MEDICAL LTD shareholders Q1 2016
NameSharesValueWeighting ↓
NORTH TIDE CAPITAL, LLC 2,350,000$28,905,0002.53%
HOURGLASS CAPITAL, LLC 838,900$10,318,0001.65%
Baupost Group 4,000,000$49,200,0001.39%
DAFNA Capital Management LLC 90,947$1,119,0001.15%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 625,567$7,694,0001.04%
Visium Asset Management, LP 3,405,000$41,882,0000.82%
PERRITT CAPITAL MANAGEMENT INC 400,000$4,920,0000.82%
Leonard Capital Management, Inc. 112,109$1,379,0000.54%
BRANDES INVESTMENT PARTNERS, LP 2,164,137$26,619,0000.33%
Broadfin Capital, LLC 200,000$2,460,0000.32%
View complete list of SYNERON MEDICAL LTD shareholders